レナリドミドは,多発性骨髄腫細胞におけるIKZF1およびIKZF3の選択的な分解を引き起こします
Jan Krönke1, Namrata D Udeshi, Anupama Narla
1Brigham and Women's Hospital, Boston, MA 02115, USA.
Science (New York, N.Y.)
|December 3, 2013
まとめ
レナリドミドは,E3ユビキチンリガゼの活性を変えることで,リンパ性転写因子IKZF1とIKZF3を選択的に分解する. このメカニズムは,多発性骨髄腫やその他のB細胞がんにおける有効性を説明する.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
背景:
- レナリドミドは,多発性骨髄腫およびB細胞腫瘍に対する効果的な治療薬です.
- レナリドミドの正確な作用機構は,ほとんど不明のままです.
- レナリドミドの分子標的を理解することは,臨床使用の最適化に不可欠です.
研究 の 目的:
- レナリドミドの作用の分子メカニズムを解明する.
- レナリドミドの特定のタンパク質標的を特定するために.
- レーナリドミドによるタンパク質分解が,その治療効果に与える影響を調査する.
主な方法:
- 定量プロテオミクスは,レナリドミド誘発のタンパク質変化を特定するために使用されました.
- 標的の関与を確認するために,ウビキチネーションと分解アッセイが行われました.
- 転写因子の遺伝子操作は,耐性メカニズムを評価するために使用されました.
主要な成果:
- レナリドミドの治療は,リンパ性転写因子IKZF1とIKZF3.3の選択的ユビキチン化と退化をもたらした.
- これらの転写因子は,多発性骨髄腫細胞の生存と増殖に不可欠です.
- IKZF3の特定の変異により,レナリドミドに対する耐性があり,細胞成長抑制を救出しました.
- IKZF1とIKZF3の枯渇は,T細胞におけるレナリドミド誘発のインタールキン-2生成にも起因していた.
結論:
- レナリドミドは,CRBN-CRL4ユビキチンリガゼ複合体を乗っ取り,IKZF1とIKZF3.3を分解することによって機能します.
- この標的型タンパク質分解は,血液学的悪性腫瘍におけるレナリドミドの有効性を裏付ける重要なメカニズムです.
- この発見は,標的型タンパク質分解のためのE3ユビキチンリガゼの調節を含む新しい治療戦略を明らかにしています.
関連する概念動画
02:57Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
01:10Drugs that Destabilize Microtubules
3.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:58Regulated Protein Degradation
6.6K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
6.6K
02:23Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
01:45Destabilization of Microtubules
2.9K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.9K